Pfizer is mentioned as a hypothetical acquirer for biotech firms, with no specific recommendation on its own shares.
Source Post
A Pharma Stock to Consider Buying Before April?
Playing FTSEMar 1, 2026
The creator highlights Axsome Therapeutics as a compelling buy ahead of a major FDA catalyst in April, citing strong revenue growth and a clear path to profitability.
Linked Mentions
Tickers discussed in this post
Axsome Therapeutics is a buy due to its narrowing losses, high gross margins, and a major upcoming FDA decision for Alzheimer's agitation.
Linked Signals
Tracked calls opened from this post
AXSM
buy opened Mar 1, 2026
+35.55%